{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:13:54Z","timestamp":1790079234658,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM12\/00155"],"award-info":[{"award-number":["CM12\/00155"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PI050167"],"award-info":[{"award-number":["PI050167"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002943","name":"Departament d'Innovaci\u00f3, Universitats i Empresa, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014SGR653"],"award-info":[{"award-number":["2014SGR653"]}],"id":[{"id":"10.13039\/501100002943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The objective of this work was to investigate the risk factors for the acquisition of<jats:italic>Pseudomonas aeruginosa<\/jats:italic>and its resistance phenotypes in critically ill patients, taking into account colonization pressure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a prospective cohort study in an 8-bed medical intensive care unit during a 35-month period. Nasopharyngeal and rectal swabs and respiratory secretions were obtained within 48\u00a0hours of admission and thrice weekly thereafter. During the study, a policy of consecutive mixing and cycling periods of three classes of antipseudomonal antibiotics was followed in the unit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 850 patients admitted for \u22653\u00a0days, 751 (88.3%) received an antibiotic, 562 of which (66.1%) were antipseudomonal antibiotics. A total of 68 patients (8%) carried<jats:italic>P. aeruginosa<\/jats:italic>upon admission, and among the remaining 782, 104 (13%) acquired at least one strain of<jats:italic>P. aeruginosa<\/jats:italic>during their stay. Multivariate analysis selected shock (odds ratio (OR) =2.1; 95% confidence interval (CI), 1.2 to 3.7), intubation (OR =3.6; 95% CI, 1.7 to 7.5), enteral nutrition (OR =3.6; 95% CI, 1.8 to 7.6), parenteral nutrition (OR =3.9; 95% CI, 1.6 to 9.6), tracheostomy (OR =4.4; 95% CI, 2.3 to 8.3) and colonization pressure &gt;0.43 (OR =4; 95% CI, 1.2 to 5) as independently associated with the acquisition of<jats:italic>P. aeruginosa<\/jats:italic>, whereas exposure to fluoroquinolones for &gt;3\u00a0days (OR =0.4; 95% CI, 0.2 to 0.8) was protective. In the whole series, prior exposure to carbapenems was independently associated with carbapenem resistance, and prior amikacin use predicted piperacillin-tazobactam, fluoroquinolone and multiple-drug resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In critical care settings with a high rate of antibiotic use, colonization pressure and non-antibiotic exposures may be the crucial factors for<jats:italic>P. aeruginosa<\/jats:italic>acquisition, whereas fluoroquinolones may actually decrease its likelihood. For the acquisition of strains resistant to piperacillin-tazobactam, fluoroquinolones and multiple drugs, exposure to amikacin may be more relevant than previously recognized.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13054-015-0916-7","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T10:45:32Z","timestamp":1430390732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure"],"prefix":"10.1186","volume":"19","author":[{"given":"Nazaret","family":"Cobos-Trigueros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Luis","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Rinaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Nicol\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Mensa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"916_CR1","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/CCM.0000000000000510","volume":"42","author":"MH Kollef","year":"2014","unstructured":"Kollef MH, Chastre J, Fagon JY, Fran\u00e7ois B, Niederman MS, Rello J, et al. Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit Care Med. 2014;42:2178\u201387.","journal-title":"Crit Care Med"},{"key":"916_CR2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/ajrccm.160.4.9809031","volume":"160","author":"MJ Bonten","year":"1999","unstructured":"Bonten MJ, Bergmans DC, Speijer H, Stobberingh EE. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control. Am J Respir Crit Care Med. 1999;160:1212\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"916_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhin.2014.06.018","volume":"88","author":"AG Venier","year":"2014","unstructured":"Venier AG, Leroyer C, Slekovec C, Talon D, Bertrand X, Parer S, et al. Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study. J Hosp Infect. 2014;88:103\u20138.","journal-title":"J Hosp Infect"},{"key":"916_CR4","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1086\/324346","volume":"33","author":"EB El Amari","year":"2001","unstructured":"El Amari EB, Chamot E, Auckenthaler R, Pech\u00e8re JC, Van Delden C. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis. 2001;33:1859\u201364.","journal-title":"Clin Infect Dis"},{"key":"916_CR5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","volume":"43","author":"Y Carmeli","year":"1999","unstructured":"Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999;43:1379\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"916_CR6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijantimicag.2010.08.005","volume":"36","author":"M Riou","year":"2010","unstructured":"Riou M, Carbonnelle S, Avrain L, Mesaros N, Pirnay JP, Bilocq F, et al. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. Int J Antimicrob Agents. 2010;36:513\u201322.","journal-title":"Int J Antimicrob Agents"},{"key":"916_CR7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1073\/pnas.97.4.1938","volume":"97","author":"M Lipsitch","year":"2000","unstructured":"Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci U S A. 2000;97:1938\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"916_CR8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1128\/AAC.46.3.854-858.2002","volume":"46","author":"AD Harris","year":"2002","unstructured":"Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA. Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother. 2002;46:854\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"916_CR9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/507288","volume":"27","author":"CMCB Fortaleza","year":"2006","unstructured":"Fortaleza CMCB, Freire MP, de Carvalho Moreira Filho D, de Carvalho Ramos M. Risk factors for recovery of imipenem- or ceftazidime-resistant Pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil. Infect Control Hosp Epidemiol. 2006;27:901\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3201\/eid\/1706.100358","volume":"17","author":"E Akhabue","year":"2011","unstructured":"Akhabue E, Synnestvedt M, Weiner MG, Bilker WB, Lautenbach E. Cefepime-resistant Pseudomonas aeruginosa. Emerg Infect Dis. 2011;17:1037\u201343.","journal-title":"Emerg Infect Dis"},{"key":"916_CR11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/317551","volume":"32","author":"P Richard","year":"2001","unstructured":"Richard P, Delangle MH, Raffi F, Espaze E, Richet H. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant Gram-negative bacilli from gastrointestinal flora. Clin Infect Dis. 2001;32:162\u20136.","journal-title":"Clin Infect Dis"},{"key":"916_CR12","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.00060-06","volume":"50","author":"KS Kaye","year":"2006","unstructured":"Kaye KS, Kanafani ZA, Dodds AE, Engemann JJ, Weber SG, Carmeli Y. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006;50:2192\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"916_CR13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1017\/S0195941700044817","volume":"27","author":"EMC D\u2019Agata","year":"2006","unstructured":"D\u2019Agata EMC, Cataldo MA, Cauda R, Tacconelli E. The importance of addressing multidrug resistance and not assuming single-drug resistance in case\u2013control studies. Infect Control Hosp Epidemiol. 2006;27:670\u20134.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1086\/338237","volume":"34","author":"AD Harris","year":"2002","unstructured":"Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis. 2002;34:340\u20135.","journal-title":"Clin Infect Dis"},{"key":"916_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/649021","volume":"31","author":"E Lautenbach","year":"2010","unstructured":"Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, et al. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol. 2010;31:47\u201353.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/660763","volume":"32","author":"AD Harris","year":"2011","unstructured":"Harris AD, Johnson JK, Thom KA, Morgan DJ, McGregor JC, Ajao AO, et al. Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting. Infect Control Hosp Epidemiol. 2011;32:719\u201322.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/339488","volume":"34","author":"JL Trouillet","year":"2002","unstructured":"Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis. 2002;34:1047\u201354.","journal-title":"Clin Infect Dis"},{"key":"916_CR18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/520740","volume":"28","author":"LB Gasink","year":"2007","unstructured":"Gasink LB, Fishman NO, Nachamkin I, Bilker WB, Lautenbach E. Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol. 2007;28:1175\u201380.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR19","doi-asserted-by":"crossref","unstructured":"Lin KY, Lauderdale TL, Wang JT, Chang SC. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: prevalence, risk factors, and impact on outcome of infections. J Microbiol Immunol Infect. In press. doi: 10.1016\/j.jmii.2014.01.005.","DOI":"10.1016\/j.jmii.2014.01.005"},{"key":"916_CR20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ajic.2009.02.003","volume":"37","author":"M L\u00f3pez-Dupla","year":"2009","unstructured":"L\u00f3pez-Dupla M, Mart\u00ednez JA, Vidal F, Almela M, Soriano A, Marco F, et al. Previous ciprofloxacin exposure is associated with resistance to \u03b2-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates. Am J Infect Control. 2009;37:753\u20138.","journal-title":"Am J Infect Control"},{"key":"916_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhin.2004.03.022","volume":"57","author":"C Defez","year":"2004","unstructured":"Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daur\u00e8s JP, et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect. 2004;57:209\u201316.","journal-title":"J Hosp Infect"},{"key":"916_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jhin.2004.03.021","volume":"57","author":"B Cao","year":"2004","unstructured":"Cao B, Wang H, Sun H, Zhu Y, Chen M. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. J Hosp Infect. 2004;57:112\u20138.","journal-title":"J Hosp Infect"},{"key":"916_CR23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/381550","volume":"38","author":"E Paramythiotou","year":"2004","unstructured":"Paramythiotou E, Lucet J, Timsit JF, Vanjak D, Paugam-Burtz C, Trouillet J, et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis. 2004;38:670\u20137.","journal-title":"Clin Infect Dis"},{"key":"916_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","volume":"50","author":"V Aloush","year":"2006","unstructured":"Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006;50:43\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"916_CR25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/AAC.00851-06","volume":"51","author":"TP Lodise","year":"2007","unstructured":"Lodise TP, Miller CD, Graves J, Furuno JP, McGregor JC, Lomaestro B, et al. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob Agents Chemother. 2007;51:417\u201322.","journal-title":"Antimicrob Agents Chemother"},{"key":"916_CR26","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1128\/AAC.03419-14","volume":"58","author":"S G\u00f3mez-Zorrilla","year":"2014","unstructured":"G\u00f3mez-Zorrilla S, Camoez M, Tubau F, Periche E, Ca\u00f1izares R, Dominguez MA, et al. Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Antimicrob Agents Chemother. 2014;58:5863\u201370.","journal-title":"Antimicrob Agents Chemother"},{"key":"916_CR27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10096-009-0850-1","volume":"29","author":"M Montero","year":"2010","unstructured":"Montero M, Sala M, Riu M, Belvis F, Salvado M, Grau S, et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition: impact of antibiotic use in a double case\u2013control study. Eur J Clin Microbiol Infect Dis. 2010;29:335\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"916_CR28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00134-008-1326-y","volume":"35","author":"JA Mart\u00ednez","year":"2009","unstructured":"Mart\u00ednez JA, Delgado E, Mart\u00ed S, Marco F, Vila J, Mensa J, et al. Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive Care Med. 2009;35:439\u201347.","journal-title":"Intensive Care Med"},{"key":"916_CR29","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","volume":"36","author":"J Chastre","year":"2008","unstructured":"Chastre J, Wunderink R, Prokocimer P, Lee M, Kaniga K, Friedland I. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Crit Care Med. 2008;36:1089\u201396.","journal-title":"Crit Care Med"},{"key":"916_CR30","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1097\/CCM.0b013e318225756d","volume":"39","author":"DSY Ong","year":"2011","unstructured":"Ong DSY, Jongerden IP, Buiting AG, Leverstein-van Hall MA, Speelberg B, Kesecioglu J, et al. Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units. Crit Care Med. 2011;39:2458\u201363.","journal-title":"Crit Care Med"},{"key":"916_CR31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1086\/518972","volume":"28","author":"TP Lodise","year":"2007","unstructured":"Lodise TP, Miller C, Patel N, Graves J, McNutt LA. Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates. Infect Control Hosp Epidemiol. 2007;28:959\u201365.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/659403","volume":"32","author":"AO Ajao","year":"2011","unstructured":"Ajao AO, Harris AD, Roghmann MC, Johnson JK, Zhan M, McGregor JC, et al. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and Clostridium difficile acquisition. Infect Control Hosp Epidemiol. 2011;32:481\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR33","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.6061\/clinics\/2013(08)11","volume":"68","author":"MF DalBen","year":"2013","unstructured":"DalBen MF, Basso M, Garcia CP, Costa SF, Toscano CM, Jarvis WR, et al. Colonization pressure as a risk factor for colonization by multiresistant Acinetobacter spp and carbapenem-resistant Pseudomonas aeruginosa in an intensive care unit. Clinics (Sao Paulo). 2013;68:1128\u201333.","journal-title":"Clinics (Sao Paulo)"},{"key":"916_CR34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.CCM.0000195010.63855.45","volume":"34","author":"JA Mart\u00ednez","year":"2006","unstructured":"Mart\u00ednez JA, Nicol\u00e1s JM, Marco F, Horcajada JP, Garcia-Segarra G, Trilla A, et al. Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med. 2006;34:329\u201336.","journal-title":"Crit Care Med"},{"key":"916_CR35","volume-title":"Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI Document M100-S19","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI Document M100-S19. Wayne, PA: CLSI; 2009."},{"key":"916_CR36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7883\/yoken.JJID.2009.372","volume":"62","author":"R Durmaz","year":"2009","unstructured":"Durmaz R, Otlu B, Koksal F, Hosoglu S, Ozturk R, Ersoy Y, et al. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis. 2009;62:372\u20137.","journal-title":"Jpn J Infect Dis"},{"key":"916_CR37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A Magiorakos","year":"2012","unstructured":"Magiorakos A, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"916_CR38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archinte.158.10.1127","volume":"158","author":"MJ Bonten","year":"1998","unstructured":"Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of \u201ccolonization pressure\u201d in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998;158:1127\u201332.","journal-title":"Arch Intern Med"},{"key":"916_CR39","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jinf.2007.07.005","volume":"55","author":"EP Hyle","year":"2007","unstructured":"Hyle EP, Gasink LB, Linkin DR, Bilker WB, Lautenbach E. Use of different thresholds of prior antimicrobial use in defining exposure: impact on the association between antimicrobial use and antimicrobial resistance. J Infect. 2007;55:414\u20138.","journal-title":"J Infect"},{"key":"916_CR40","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/AAC.00456-08","volume":"52","author":"N Patel","year":"2008","unstructured":"Patel N, McNutt LA, Lodise TP. Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008;52:2933\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"916_CR41","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1086\/501721","volume":"21","author":"J Merrer","year":"2000","unstructured":"Merrer J, Santoli F, App\u00e9r\u00e9 de Vecchi C, Tran B, De Jonghe B, Outin H. \u201cColonization pressure\u201d and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2000;21:718\u201323.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/511793","volume":"28","author":"SJ Lawrence","year":"2007","unstructured":"Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007;28:123\u201330.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"916_CR43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhin.2006.11.010","volume":"65","author":"EG Playford","year":"2007","unstructured":"Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect. 2007;65:204\u201311.","journal-title":"J Hosp Infect"},{"key":"916_CR44","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/cc10026","volume":"15","author":"A Boyer","year":"2011","unstructured":"Boyer A, Doussau A, Thi\u00e9bault R, Venier AG, Tran V, Boulestreau H, et al. Pseudomonas aeruginosa acquisition on an intensive care unit: relationship between antibiotic selective pressure and patients\u2019 environment. Crit Care. 2011;15:R55.","journal-title":"Crit Care"},{"key":"916_CR45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ajic.2012.03.016","volume":"41","author":"CM Castelo Branco Fortaleza","year":"2013","unstructured":"Castelo Branco Fortaleza CM, Moreira de Freitas F, da Paz Lauterbach G. Colonization pressure and risk factors for acquisition of imipenem-resistant Acinetobacter baumannii in a medical surgical intensive care unit in Brazil. Am J Infect Control. 2013;41:263\u20135.","journal-title":"Am J Infect Control"},{"key":"916_CR46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/S1413-86702009000300004","volume":"13","author":"CMCB Fortaleza","year":"2009","unstructured":"Fortaleza CMCB, Figueiredo LC, Beraldo CC, de Melo EC, P\u00f3la PMS, Arag\u00e3o VDN. Risk factors of oropharyngeal carriage of Pseudomonas aeruginosa among patients from a medical-surgical intensive care unit. Braz J Infect Dis. 2009;13:173\u20136.","journal-title":"Braz J Infect Dis"},{"key":"916_CR47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3201\/eid1001.020663","volume":"10","author":"MJ Schwaber","year":"2004","unstructured":"Schwaber MJ, Cosgrove SE, Gold HS, Kaye KS, Carmeli Y. Fluoroquinolones protective against cephalosporin resistance in Gram-negative nosocomial pathogens. Emerg Infect Dis. 2004;10:94\u20139.","journal-title":"Emerg Infect Dis"},{"key":"916_CR48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijantimicag.2007.05.022","volume":"30","author":"S Bhat","year":"2007","unstructured":"Bhat S, Fujitani S, Potoski BA, Capitano B, Linden PK, Shutt K, et al. Pseudomonas aeruginosa infections in the intensive care unit: can the adequacy of empirical \u03b2-lactam antibiotic therapy be improved? Int J Antimicrob Agents. 2007;30:458\u201362.","journal-title":"Int J Antimicrob Agents"},{"key":"916_CR49","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","volume":"44","author":"N Masuda","year":"2000","unstructured":"Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:3322\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"916_CR50","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/AAC.01758-13","volume":"58","author":"AF Voor in \u2019t holt","year":"2014","unstructured":"Voor in \u2019t holt AF, Severin JA, Lesaffre EMEH, Vos MC. A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58:2626\u201337.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-015-0916-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0916-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T23:02:48Z","timestamp":1691622168000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-015-0916-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1186\/s13054-015-0916-7","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"26 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"218"}}